Header Logo

Connection

MICHAEL A DAVIES to Melphalan

Back to Details
This is a "connection" page, showing publications MICHAEL A DAVIES has written about Melphalan.
MICHAEL A DAVIES
Connection Strength
0.020
Melphalan
  1. A phase I multi-institutional study of systemic sorafenib in conjunction with regional melphalan for in-transit melanoma of the extremity. Ann Surg Oncol. 2012 Nov; 19(12):3896-3905.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.